1,2-dimethylhydrazine multiple interactions ISO RGD:733252 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DCTPP1 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene decreases expression EXP 6480464 Dinitrochlorobenzene results in decreased expression of DCTPP1 mRNA CTD PMID:17374397 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of DCTPP1 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of DCTPP1 mRNA CTD PMID:21496263 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:620933 6480464 Tetrachlorodibenzodioxin results in increased expression of DCTPP1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:620933 6480464 Tetrachlorodibenzodioxin affects the expression of DCTPP1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:620933 6480464 Tetrachlorodibenzodioxin results in decreased expression of DCTPP1 mRNA CTD PMID:32109520 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:620933 6480464 2 more ... CTD PMID:32109520 2,4,6-trinitrotoluene affects expression ISO RGD:620933 6480464 Trinitrotoluene affects the expression of DCTPP1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression ISO RGD:620933 6480464 2, 6-dinitrotoluene affects the expression of DCTPP1 mRNA CTD PMID:21346803 4,4'-diaminodiphenylmethane decreases expression ISO RGD:733252 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of DCTPP1 mRNA CTD PMID:18648102 4-(ethoxymethylene)-2-phenyloxazol-5-one decreases expression EXP 6480464 Oxazolone results in decreased expression of DCTPP1 mRNA CTD PMID:17374397 6-propyl-2-thiouracil increases expression ISO RGD:620933 6480464 Propylthiouracil results in increased expression of DCTPP1 mRNA CTD PMID:24780913 acetamide increases expression ISO RGD:620933 6480464 acetamide results in increased expression of DCTPP1 mRNA CTD PMID:31881176 acrylamide increases expression ISO RGD:620933 6480464 Acrylamide results in increased expression of DCTPP1 mRNA CTD PMID:28959563 ammonium chloride affects expression ISO RGD:620933 6480464 Ammonium Chloride affects the expression of DCTPP1 mRNA CTD PMID:16483693 arsenite(3-) multiple interactions EXP 6480464 arsenite promotes the reaction [G3BP1 protein binds to DCTPP1 mRNA] CTD PMID:32406909 benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of DCTPP1 promoter CTD PMID:27901495 bisphenol A increases expression ISO RGD:620933 6480464 bisphenol A results in increased expression of DCTPP1 mRNA CTD PMID:18180321 bisphenol A increases expression ISO RGD:733252 6480464 bisphenol A results in increased expression of DCTPP1 mRNA CTD PMID:33221593 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of DCTPP1 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:620933 6480464 bisphenol A results in decreased expression of DCTPP1 mRNA CTD PMID:26982218 captan decreases expression ISO RGD:733252 6480464 Captan results in decreased expression of DCTPP1 mRNA CTD PMID:31558096 carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of DCTPP1 mRNA CTD PMID:24752500 carbon nanotube increases expression ISO RGD:733252 6480464 Nanotubes more ... CTD PMID:25554681 cefaloridine increases expression ISO RGD:620933 6480464 Cephaloridine results in increased expression of DCTPP1 mRNA CTD PMID:18500788 chloropicrin decreases expression EXP 6480464 chloropicrin results in decreased expression of DCTPP1 mRNA CTD PMID:26352163 chromium(6+) affects expression ISO RGD:733252 6480464 chromium hexavalent ion affects the expression of DCTPP1 mRNA CTD PMID:28472532 clofibrate decreases expression ISO RGD:733252 6480464 Clofibrate results in decreased expression of DCTPP1 mRNA CTD PMID:17585979 clofibrate multiple interactions ISO RGD:733252 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of DCTPP1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of DCTPP1 mRNA] CTD PMID:17585979 clofibric acid multiple interactions ISO RGD:620933 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DCTPP1 mRNA CTD PMID:17602206 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of DCTPP1 mRNA CTD PMID:19376846 copper atom multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in decreased expression of DCTPP1 mRNA CTD PMID:20971185 copper(0) multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in decreased expression of DCTPP1 mRNA CTD PMID:20971185 copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of DCTPP1 mRNA CTD PMID:19549813 coumestrol increases expression EXP 6480464 Coumestrol results in increased expression of DCTPP1 mRNA CTD PMID:19167446 crocidolite asbestos increases expression EXP 6480464 Asbestos, Crocidolite results in increased expression of DCTPP1 mRNA CTD PMID:29523930 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of DCTPP1 mRNA CTD PMID:25562108 dibutyl phthalate decreases expression ISO RGD:733252 6480464 Dibutyl Phthalate results in decreased expression of DCTPP1 mRNA CTD PMID:21266533 diclofenac affects expression EXP 6480464 Diclofenac affects the expression of DCTPP1 mRNA CTD PMID:24752500 dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of DCTPP1 mRNA CTD PMID:26516004 dioxygen multiple interactions ISO RGD:733252 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DCTPP1 mRNA CTD PMID:30529165 disodium selenite increases expression EXP 6480464 Sodium Selenite results in increased expression of DCTPP1 mRNA CTD PMID:18175754 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCTPP1 mRNA CTD PMID:27188386 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of DCTPP1 mRNA CTD PMID:29803840 enzyme inhibitor multiple interactions EXP 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DCTPP1 protein CTD PMID:23301498 flutamide increases expression ISO RGD:620933 6480464 Flutamide results in increased expression of DCTPP1 mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:733252 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DCTPP1 mRNA CTD PMID:22206623 folpet decreases expression ISO RGD:733252 6480464 folpet results in decreased expression of DCTPP1 mRNA CTD PMID:31558096 furan increases expression ISO RGD:620933 6480464 furan results in increased expression of DCTPP1 mRNA CTD PMID:25539665 hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of DCTPP1 mRNA CTD PMID:20044591 ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of DCTPP1 protein CTD PMID:32959892 leflunomide decreases expression ISO RGD:620933 6480464 leflunomide results in decreased expression of DCTPP1 mRNA CTD PMID:24136188 N-methyl-4-phenylpyridinium decreases expression ISO RGD:733252 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of DCTPP1 protein CTD PMID:26558463 N-nitrosodiethylamine multiple interactions ISO RGD:620933 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DCTPP1 mRNA CTD PMID:17602206 nickel sulfate decreases expression EXP 6480464 nickel sulfate results in decreased expression of DCTPP1 mRNA CTD PMID:17374397 oxaliplatin multiple interactions ISO RGD:620933 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of DCTPP1 mRNA CTD PMID:25729387 oxaliplatin decreases expression ISO RGD:620933 6480464 oxaliplatin results in decreased expression of DCTPP1 mRNA CTD PMID:25729387 paracetamol multiple interactions ISO RGD:733252 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of DCTPP1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of DCTPP1 mRNA] CTD PMID:17585979 paracetamol increases expression ISO RGD:620933 6480464 Acetaminophen results in increased expression of DCTPP1 mRNA CTD PMID:33387578 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of DCTPP1 mRNA CTD PMID:21420995 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCTPP1 mRNA CTD PMID:27188386 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of DCTPP1 mRNA CTD PMID:28595984 , PMID:34032870 sodium dichromate decreases expression ISO RGD:733252 6480464 sodium bichromate results in decreased expression of DCTPP1 mRNA CTD PMID:31558096 sunitinib decreases expression EXP 6480464 Sunitinib results in decreased expression of DCTPP1 mRNA CTD PMID:31533062 temozolomide increases expression EXP 6480464 Temozolomide results in increased expression of DCTPP1 mRNA CTD PMID:31758290 testosterone increases expression EXP 6480464 Testosterone results in increased expression of DCTPP1 mRNA CTD PMID:33359661 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of DCTPP1 mRNA CTD PMID:22378314 thioacetamide increases expression ISO RGD:620933 6480464 Thioacetamide results in increased expression of DCTPP1 mRNA CTD PMID:23411599 , PMID:34492290 toluene decreases expression ISO RGD:620933 6480464 Toluene results in decreased expression of DCTPP1 mRNA CTD PMID:22967744 topotecan decreases expression ISO RGD:620933 6480464 Topotecan results in decreased expression of DCTPP1 mRNA CTD PMID:25729387 topotecan multiple interactions ISO RGD:620933 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of DCTPP1 mRNA CTD PMID:25729387 trimellitic anhydride increases expression ISO RGD:733252 6480464 trimellitic anhydride results in increased expression of DCTPP1 mRNA CTD PMID:19042947 tungsten increases expression ISO RGD:733252 6480464 Tungsten results in increased expression of DCTPP1 mRNA CTD PMID:30912803 tunicamycin decreases expression EXP 6480464 Tunicamycin results in decreased expression of DCTPP1 mRNA CTD PMID:22378314 urethane decreases expression EXP 6480464 Urethane results in decreased expression of DCTPP1 mRNA CTD PMID:28818685 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of DCTPP1 mRNA CTD PMID:25979313 valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCTPP1 mRNA CTD PMID:27188386 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of DCTPP1 mRNA CTD PMID:23179753 , PMID:26272509 vinclozolin decreases expression ISO RGD:620933 6480464 vinclozolin results in decreased expression of DCTPP1 mRNA CTD PMID:23034163 vinclozolin increases methylation ISO RGD:620933 6480464 vinclozolin results in increased methylation of DCTPP1 gene CTD PMID:31079544